^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    engineered autologous T cells

    i
    Other names: engineered autologous T cells, autologous chimeric T lymphocytes targeted to prostate-specific membrane antigen (PSMA)
    Associations
    News
    Trials
    Company:
    Memorial Sloan-Kettering Cancer Center
    Drug class:
    PSMA-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials